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Targeted Disruption of the Mouse Stat1 Gene
Results in Compromised Innate Immunity
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Given the inherent specificity of SH2±phosphopeptideand Kaplan Cancer Center
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selectivity is possible for STAT dimerizations and forNew York, New York 10016
STAT activation by different ligand±receptor combina-²Department of Medicine
tions. For example, STAT1 and STAT2 and STAT1 andand Howard Hughes Medical Institute
STAT3 combine to form distinct DNA-binding com-University of Chicago
plexes, but interaction of STAT1 or STAT2 with otherChicago, Illinois 60637
STAT family members has not been reported. Similarly,
STAT1 docks to the sequence YDKPH in the IFNg recep-
tor (Greenlund et al., 1994), while STAT3 docks to the
Summary sequence YXXQ found in the gp130 signaling chain of
the interleukin-6 (IL-6) receptor (Stahl et al., 1995). Swap-
ping these sequences between receptors or swappingThe STAT1 transcription factor is activated in re-
the SH2 domains of STAT proteins transfers thespecific-sponse to many cytokines and growth factors. To
ity of STAT docking and activation between receptorsstudy the requirement for STAT1 in vivo, we disrupted
(Heim et al., 1995; Stahl et al., 1995). These mechanismsthe Stat1 gene in embryonic stem (ES) cells and in
for discrimination of substrates for different cytokinemice. Stat12/2 ES cells were unresponsive to interferon
receptors support the contention that receptor associ-(IFN), but retained responsiveness to leukemia inhibi-
ated transcription factor activation and direct nucleartory factor (LIF) and remained LIF dependent for undif-
translocation afford a high degree of signaling speci-ferentiated growth. Stat12/2 animals were born at
ficity.normal frequencies and displayed no gross develop-
In spite of this apparent specificity, a wide range ofmental defects. However, these animals failed to thrive
cytokines, growth factors, and other signaling mole-and were extremely susceptible to viral disease. Cells
cules, acting through a variety of receptor systems, haveand tissues from Stat12/2 mice were unresponsive to
been shown to activate STAT1 in cell culture systems.IFN, but remained responsive to all other cytokines
In addition, ligand-independent STAT phosphorylationtested. Thus, STAT1 appears to be specific for IFN
by oncoprotein tyrosine kinases hasbeen reported, sug-pathways that are essential for viability in the face of
gesting a seemingly indiscriminate action of these tran-otherwise innocuous pathogens.
scription factors. In addition to the IFN system, the cyto-
kine receptors for IL-6, leukemia inhibitory factor (LIF),
oncostatin M, growth hormone, prolactin, and IL-10Introduction
(Campbell et al., 1995; David et al., 1994; Larner et al.,
1993; Raz et al., 1994; Sadowski et al., 1993); the trans-Characterization of the signaling pathways employed
membrane protein tyrosine kinase receptors for epider-by interferon-a (IFNa) for the rapid induction of gene
mal growth factor (EGF), platelet-derived growth factorexpression led to discovery of a family of transcription
(PDGF), and colony-stimulating factor 1 (CSF-1) (Ruff-factors proposed todirectly link cell surface receptors to
Jamison et al., 1993; Sadowski et al., 1993; Silvennoinennuclear events (Levy and Darnell, 1990). These proteins,
et al., 1993b); and the G protein±linked receptor for an-termed signal transducers and activators of transcrip-
giotensin II (Bhat et al., 1994; Marrero et al., 1995) havetion, or STATs, reside outside the nucleus in untreated
all been shown to activate STAT1. These observations
cells. Upon stimulation with IFN, they become activated
prompted a reexamination of the specificity of STAT1
by tyrosine phosphorylation, multimerize, and translo-
utilization in signaling pathways.
cate to the nucleus, where they recognize discrete cis- Chemically mutagenized human fibrosarcoma cells
acting regulatory sequences in DNA (for reviews see defective in STAT1 have been isolated and used to dem-
Darnell et al., 1994; Schindler and Darnell, 1995; Levy, onstrate the requirement for STAT1 in IFN responses
1995). Tyrosine phosphorylation of STAT transcription (MuÈ ller et al., 1993b). However, the lack of respon-
factors involves Janus protein tyrosine kinases (JAKs) siveness of the parental cell line to other cytokines
(Ihle and Kerr, 1995). The response to IFNa requires the (Guschin et al., 1995; Leaman et al., 1996) and the un-
JAKs JAK1 and TYK2 while the response to IFNg uses characterized nature of the STAT1 defect have made
JAK1 and the related kinase JAK2 (MuÈ ller et al., 1993a; generalizations concerning STAT1 function difficult to
Silvennoinen et al., 1993a; Watling et al., 1993). draw. To investigate further the generality of STAT1
STAT transcription factor activity depends on the in- involvement in cytokine signaling and to probe the roles
teraction of SH2 domains with phosphotyrosine resi- of STAT1-linked pathways under physiologic settings
dues. Multimerization as homo- or heterodimers in- and during development, we disrupted the gene for
volves intermolecular interaction between STAT SH2 STAT1 in embryonic stem (ES) cells and in mice. Exami-
domains and a phosphorylated tyrosine residue near nation of homozygous mutant cells and animals devoid
the carboxyl terminus (Shuai et al., 1994). Likewise, acti- of functional STAT1 protein revealed that STAT1 is indis-
pensable for the IFN pathway, but may not be necessaryvation of STAT proteins by receptor-associated JAKs is
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Figure 1. Targeted Disruption of the Stat1
Locus
(A) Top diagram shows a portion of the mouse
Stat1 locus with exons (boxes) and relevant
restriction sites indicated (solid boxes repre-
sent exons whose positions have been pre-
cisely mapped by DNA sequencing; stippled
boxes represent exons whose position on the
map is estimated). The position of the probe
used for RFLP analysis is indicated. The mid-
dle diagram shows the targeting construct
pPNT-91. Hatched boxes represent portions
of the Stat1 genomic locus used as recombi-
nation arms; arrows represent the direction
of transcription of the neomycin resistance
and thymidine kinase genes. The bottom dia-
gram represents the Stat1 mRNA, with the
portion deleted by homologous recombina-
tion shown as stippled.
(B) Southern blot analysis of genomic DNA
from targeted ES cells. Wild-type (5.5 kb) and
disrupted (8.8 kb) KpnI fragments are indi-
cated. Lanes 1±5 show DNA from ES cells
derived from the primary targeting event;
lanes 6±9 show DNA from ES cells grown in
1.4 mg/ml G418 to select for homozygous
Stat12/2. Genotypes are indicated.
for other signaling systems or for normal development. Phenotype of Stat12/2 ES Cells
Since STAT1 is activated by IFNs and other cytokines,However, mutant animals demonstrated the essential
nature of a STAT1-dependent system for survival in the we tested the transcriptional response of Stat12/2 ES
cells (Figure 2). Feeder cell-free cultures of both Stat11/1face of otherwise innocuous viral pathogens.
and Stat12/2 ES cells were stimulated with LIF or with
IFNg plus IFNa prior to lysis and recovery of RNA. North-Results
ern blots were probed for induction of IFN-regulatory
factor 1 (IRF-1) mRNA (Fujita et al., 1988; Pine et al.,Disruption of the Mouse Stat1 Gene
A functionally null Stat1 allele was produced by deleting 1990), an IFN- and LIF-inducible gene regulated through
a STAT1-binding promoter site (Pine et al., 1994; Simsa portion of protein coding region by gene targeting
(see Experimental Procedures). The targeting construct et al., 1993), and for glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH), a constitutively transcribed gene.resulted in the loss of 5.7 kb of genomic DNA that con-
tains three complete exons and a portion of a fourth IRF-1 was strongly induced by IFN treatment and mod-
erately by LIF in Stat11/1 cells (Figure 2, lanes 2 and 3).that encode amino acids 221±365. This deletion results
in loss of a portion of the DNA-binding domain (Schindler In contrast, Stat12/2 cells did not induce IRF-1 in re-
sponse to IFN treatment. However, these cells still in-et al., 1995), ensuring a functionally inert protein. In addi-
tion, any splicing event that circumvented the neomycin duced IRF-1 to normal levels in response to LIF, in spite
of the fact that LIF also stimulates STAT1 phosphoryla-resistance cassette would produce an mRNA with an
altered reading frame, and the neomycin resistance cas- tion. In addition, both of these ES cell cultures remained
dependent for growth on the presence of LIF, quicklysette was placed in the opposite transcriptional orienta-
tion to STAT1 potentially to produce transcriptional in- differentiating into nongrowing cells with substantially
terference, further inactivating the Stat1 gene (Figure
1A). Targeted ES cells were identified by production of
a novel 8.8 kb KpnI restriction fragment length polymor-
phism (RFLP) in addition to the wild-type 5.5 kb allele
(Figure 1B, lanes 2 and 4).
ES cells homozygous for the Stat1 disruption were
selected by growth in high concentrations of G418 (Mor-
tensen et al., 1992). Reduction to homozygosity was
monitored by using the KpnI RFLP analysis for loss of
the 5.5 kb wild-type fragment (Figure 1B, lane 7). Three
homozygous mutant ES cell lines were recovered from
approximately 150 clones resistant to growth in 1.4
Figure 2. Stat12/2 ES Cells Respond to LIF but Not IFN
mg/ml G418. Wild-type, Stat11/2 heterozygote, and
Stat11/1 (lanes 1±3) and Stat12/2 (lanes 4±6) feeder cell-free ES cellStat12/2 homozygote ES cells were adapted to growth
cultures were deprived of LIF and treated with medium alone (lanes
in the absence of feeder fibroblasts by culturing on plas- 1 and 4), with 10 ng/ml LIF for 1 hr (lanes 2 and 5), or with 5 ng/ml
tic dishes coated with type I collagen in medium con- IFNg for 24 hr followed by 500 U/ml IFNa/b for 1 hr (lanes 3 and 6).
RNA blots were hybridized with the indicated probes.taining LIF.
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3C). Protein±DNA complexes characteristic of activated
STAT1, STAT3, and STAT1±STAT3 heterodimers were
detected in extracts from IFNg-treated Stat11/1 cells
(Figure 3C, lane 2), similar to patterns detected in some
but not all cultured cells (Campbell et al., 1995; Raz et
al., 1994), while only activated STAT3 was observed in
extracts derived from Stat12/2 cells (lane 3). Activated
STAT3 was also detected in response to IFNa (data not
shown). Thus, STAT3 phosphorylation shows no depen-
dence on the presence or activity of STAT1 (Guschin et
al., 1995).
Stat11/1, Stat11/2, and Stat12/2 progeny were born at
the expected frequencies from heterozygous matings,
demonstrating that no gross developmental abnormali-
ties were caused by the mutation (data not shown).How-
ever, homozygous mutant animals tended to be runted
relative to their wild-type and heterozygous siblings.
More significantly, all Stat12/2 animals died within 48 hr
of weaning. To date, no homozygous animal born in this
initial colony has survived greater than 8 weeks, even
if not removed from its mother.
Since these animals were raised in a conventionalFigure 3. Stat12/2 Animals Produce No STAT1 Protein
rodent colony, the protective effect of suckling the
(A) RFLP analysis of three progeny from a mating between Stat11/2
Stat12/2 animals suggested that mortality was due to ananimals. Genotypes are indicated.
infectious agent to which the mother provided milkborn(B) Western blot of anti-STAT1 immunoprecipitates of spleen cell
extracts from Stat11/1 (lane 1) and Stat12/2 (lane 2) mice were probed immunity. Necropsy of mutant animals consistently re-
with a STAT1 monoclonal antibody. vealed significant hepatic disease. Histologic examina-
(C) Electrophoretic mobility shift assay using a high affinity STAT- tion of liver tissue from homozygous animals dying of
binding site probe. Extracts from cultured mouse embryo fibroblasts
disease or euthanized in extremis showed multifocalfrom Stat11/1 (lanes 1 and 2) or Stat12/2 animals (lane 3) untreated
hepatic necrosis with syncytial cell formation (Figure 4A)(lane 1) or treated for 15 min with 5 ng/ml IFNg (lanes 2 and 3)
and scant inflammatory response, consistent with viralwere assayed for activated STATs. The mobility of STAT1±DNA and
STAT3±DNA complexes are shown. The intermediate band (lane 2) hepatitis. Microscopic analysis of hepatic tissue taken
is due to STAT1±STAT3 heterodimers. from wild-type or heterozygous siblings sacrificed at the
same age demonstrated no pathology (Figure 4B). In
addition to liver lesions, some Stat12/2 animals displayed
altered morphology in the absence of this cytokine (data intestinal lesions consisting of necrotic foci with syncy-
not shown). Thus, Stat12/2 ES cells are deficient in their tial giantcells. These histopathologic findings are patho-
response to IFN but retain at least two responses for gnomonic for infection with mouse hepatitis virus (MHV),
the cytokine LIF, induction of IRF-1 mRNA, and mainte- a common rodent pathogen that was detected serologi-
nance of the undifferentiated state. ES cells were also cally in Stat11/2 breeding females (data not shown). MHV
allowed to differentiate in vitro into hematopoietic em- infection is typically subclinical, with significant though
bryoid bodies (Simon et al., 1992). No differences were often only limited mortality confined tocolonies of immu-
noted between Stat11/1 and Stat12/2 cells in develop- nocompromised animals (Compton et al., 1993).
ment of erythroblasic or monocytic lineages; however,
differentiated cells, like their undifferentiated progeni-
tors, failed to respond to IFN (data not shown). Extraordinary Sensitivity to Viral Pathogens
in the Absence of STAT1
The lethality produced by endemic MHV prompted usStat12/2 Animals Are Susceptible
to Opportunistic Infections to examine responses to additional viral pathogens.
Stat11/2 embryos were transferred to clean hosts andUndifferentiated heterozygous Stat11/2 ES cells were
injected into normal mouse blastocysts to derive a specific pathogen-free progeny were interbred under
specific pathogen-free conditions. Stat12/2 animals ob-Stat12/2 strain. Stat11/2 animals were interbred for pro-
duction of homozygous progeny that were detected by tained in this colony displayed no symptoms of sponta-
neous disease. However, these animals were very sus-RFLP analysis (Figure 3A, lane 3). Absence of STAT1
protein in homozygous animals was confirmed by immu- ceptible to viral challenge. Infection with 5000 pfu of
vesicular stomatitis virus (VSV) proved lethal to Stat12/2noprecipitation and immunoblotting with antibodies
specific for STAT1 (Figure 3B). No STAT1 protein could animals within 2 days, while Stat11/1 littermates were
capable of surviving infection with a 106-fold higher dosebe detected, even using a carboxyl terminus±specific
antibody, showing that even if splicing circumvented (Table 1). Virus replicated to extremely high titers in
Stat12/2 animals while Stat11/1 animals eliminated thethe neomycin cassette, no stable protein was produced.
In addition, no activated STAT1 could be detected by virus within 2 days (Table 1).
To determine whether the absence of resistance toa DNA-binding assay of extracts from IFN-treated em-
bryonic fibroblasts derived from mutant animals (Figure infection was due to a profound defect in the immune
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Figure 4. Stat12/2 Animals Die from Liver Ne-
crosis Due to MHV Infection
Histological sections from Stat12/2 (A) and
Stat11/1 (B) animals show fulminant liver ne-
crosis and syncytial giant cells in livers from
Stat12/2 mice. Magnification, 4003.
Table 1. Survival Following VSV Infection
Stat11/1 Stat12/2
Inoculuma 1 day 2 day 3 day Virusb 1 day 2 day 3 day Virus
5 3 109 3 of 3 3 of 3 2 of 3 Ðc Ð Ð Ð Ð
5 3 108 3 of 3 3 of 3 3 of 3 Ð Ð Ð Ð Ð
5 3 107 3 of 3 3 of 3 3 of 3 ,100 2 of 3 0 of 3 0 of 3 .1010
5 3 105 Ð Ð Ð Ð 3 of 3 0 of 3 0 of 3 Ð
5 3 103 Ð Ð Ð Ð 3 of 3 0 of 3 0 of 3 .1010
Mock Ð Ð Ð Ð 2 of 2 2 of 2 2 of 2 Ð
a Animals were inoculated intravenously with VSV (Indiana) diluted in 100 ml of phosphate-buffered saline. Stat11/1 animals were infected with
doses ranging from 5 3 105 pfu to 5 3 109 pfu per animal, while Stat12/2 animals received doses from 5 3 103 pfu to 5 3 107 pfu per animal.
Infected animals displayed respiratory distress indicative of viral disease prior to death. Mock-infected animals receiving only phosphate-
buffered saline showed no signs of disease.
b Viral titers (pfu/g) in livers were determined 2 days postinfection.
c A dash means not determined or not applicable.
system, we characterized the lymphoid and myeloid lanes 5 and 6). However, spleens from Stat12/2 animals
failed to mount a transcriptional response to IFN (Figurecompartments by flow cytometry (Figure 5). Normal pro-
duction of B lymphocytes (Figure 5A) and monocytes 6A, lanes 2 and 3). Furthermore, even the basal level of
p48 observed in Stat11/1 animals (Figure 6A, lane 4)(Figure 5B) was detected in fetal liver from Stat12/2 ani-
mals. Similarly, normal production of T lymphocytes was was reduced in RNA from mutant animals, suggesting
a possible role for STAT1 even in the absence of exoge-observed in neonatal thymus (Figure 5C). Granulocytes
were also produced in normal numbers (Figure 5D). nous IFN.
Transcriptional responses to IFN were tested in tis-
sues derived from mutant animals. Splenocytes har- Transcriptional Responses Not Induced by
IFN Appear Normal in Stat12/2 Animalsvested from wild-type and Stat12/2 animals were cul-
tured in the absence or presence of IFN. Northern blots Absence of a transcriptional response to IFN in mutant
animals prompted us to examine responses to otherof recovered RNA showed that such IFN-induced genes
as ISG54, IRF-1, and ISGF3g p48 were induced by either cytokinesknown to causeSTAT1 phosphorylation. Bone
marrow macrophages were isolated from the femurs ofIFNa or IFNg in spleens from normal animals (Figure 6A,
Figure 5. Normal Lymphoid and Monocyte
Development in Stat12/2 Mice
Immunofluorescent flow cytometirc analysis
of fetal liver (A, B, and D) or neonatal thymus
(C) for B2201CD431 B cells, CD11b1CD181
monocytes, CD41CD81 T cells, and Gr-11
granulocytes showed normal patterns of he-
matopoiesis in Stat11/1 (top) and Stat12/2
(bottom) animals.
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normal or homozygous mutant animals and cultured for differences were detected in the induction of IFN mRNA
in infected fibroblasts of either genotype (Figure 6C).7 days in medium supplemented with CSF-1. Morpho-
logically indistinguishable macrophages were obtained Therefore, ISGF3 is not required for IFN gene expres-
sion, at least in fibroblasts. In addition, normal levels offrom animals of both genotypes and cells from mutant
animals, like the spleen cell cultures, failed to respond IFN gene expression can be obtained in the absence of
any priming effects consequent to IFN action.transcriptionally to IFN. However, induced transcription
of mRNA encoding FcgR1, IRF-1, and ICAM-1 following
IL-6 treatment (Lord et al., 1990) were indistinguishable
Discussionin cells of either genotype (data not shown).
Similarities exist between transcriptional responses
STAT1 protein was originally discovered because of itsto IFN and induction of IFN mRNA in response to virus
role in response to IFNs. It is tyrosine phosphorylatedinfection. In particular, IFN is known to prime cells to
in response to all types of IFN and participates in thebecome more sensitive to IFN production in response
formation of the multimeric transcription factors ISGF3to virus (Havell and Vilcek, 1972) and IRF-1, which may
in response to IFNa and IFNg activation factor in re-play some role in IFN induction (Fujita et al., 1989), is
sponse to IFNg. Since it is also activated in responseinduced by IFN through a STAT1-dependent pathway
to a wide variety of other cytokines and growth factors,(Pine et al., 1994; Sims et al., 1993). In addition, a role
it has been suggested to play a fairly general role infor ISGF3 in IFN gene induction was recently suggested
transcriptional responses, rather than lending specificity(Kawakami et al., 1995). Therefore, we tested for any
to IFN responses, as originally proposed. However, dis-dependence of the production of IFNa and IFNb in re-
ruption of the Stat1 gene demonstrates that its primary,sponse to virus infection on STAT1 activity. Embryonic
if not exclusive, role is in transcriptional responses tofibroblasts derived from normal and Stat12/2 animals
IFN. In addition, these results demonstrate the essentialwere infected with Newcastle disease virus in the pres-
nature of innate immunity for survival. Although Stat12/2ence of cycloheximide. RNA recovered from untreated
animals were born at normal frequencies and appearedand treated cells was analyzed by Northern blotting us-
to grow and develop similar to wild-type counterparts,ing probes for mouse IFNa4 and IFNb. No consistent
they failed to survive in the presence of otherwise innoc-
uous pathogens. This failure to thrive occurred in spite
of the apparent normal development of the cells and
organs of the immune system.
Histologic examination of Stat12/2 animals was con-
sistent with a diagnosis of MHV infection, a normally
innocuous pathogen that was detected serologically in
breeding females but demonstrated no obvious clinical
manifestation in wild-type or heterozygous animals. The
observation that mortality was delayed in nursing ani-
mals suggests that maternally derived immunity is a
significant factor in the resistance to this pathogen.
However, in the absence of STAT1, even passive mater-
nal immunity during the perinatal period is insufficient
for survival to adulthood. Stat12/2 mutant animals rede-
rived by embryo transfer and raised in a specific patho-
gen-free rodent facility were healthy and fertile. How-
ever, these animals were very susceptible to viral
disease: inoculation with VSV at doses at least 106-fold
lower than an LD50 for Stat11/1 mice proved fatal in all
animals tested. That no mutant animals were able to
survive to adulthood in the presence of endemic MHV
demonstrates the essential nature of innate immunity
for combatting pathogens likely to be encountered in the
wild. MHV infections are normally subclinical in rodents,
especially in immunocompetent animals. In fact, even
in immunocompromised hosts, naturally acquired MHV
Figure 6. Transcriptional Responses to IFN Are Absent in Stat12/2
infection is rarely fatal but rather produces a chronicMice
infection with animals constantly shedding virus. Con-
(A) RNA isolated from spleens of Stat12/2 (lanes 1±3) or normal mice
sistent with the mild nature of the disease, the level(lanes 4±6) untreated (lanes 1 and 4) or treated for 7 hr with 500
of infection in our colony has not caused significantU/ml IFNa/b (lanes 2 and 5) or for 1 hr with 5 ng/ml IFNg (lanes 3
and 6) was analyzed for induction of ISG54, IRF-1, p48, and GAPDH mortality among normal animals or even among a variety
mRNA, as indicated. of immunocompromised strains that have been housed
(B) Normal induction of IFN gene expression in response to virus. in the facility (P. Glennon, personal communication).
Mouse embryo fibroblasts from mice of the indicated genotypes Thus, STAT1-dependent innate immunity, presumably
were treated with cycloheximide and either left untreated (lanes 1
produced in response to IFN, appears to be the crucialand 3) or infected with Newcastle disease virus (lanes 2 and 4). RNA
host defense mechanism combating MHV disease.was analyzed for induction of IFNa (top), IFNb (middle), or GAPDH
(bottom). Susceptibility of Stat12/2 animals to viral disease is
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consistent with the requirement of IFNa/b receptors for in response to IFN (Bluyssen et al., 1995; Veals et al.,
1993). On the other hand, both STAT1 and STAT3 areresistance to VSV and pseudorabies infections and the
requirement of IFNg receptors for resistance to vaccinia capable of binding and activating the enhancer of the
IRF-1 gene (Pine et al., 1994; Sims et al., 1993; Lamb etvirus infection (Huang et al., 1993; MuÈ ller et al., 1994;
Schijns et al., 1994; Steinhoff et al., 1995). It has also al., 1995). Apparently, however, STAT3 alone activated
in response to IFNa cannot function through this site,been reported that passive depletion of IFNg by adminis-
tration of specific antibodies in vivo results in enhanced since IRF-1 was not induced in Stat12/2 cells by IFN.
Perhaps additional modifications of STAT3 that occursensitivity toa variety of viruses, including MHV (Smith et
al., 1991). However, in the absence of an IFNg response in response to IL-6 family cytokines, but not in response
to IFNa, are critical for its function (Boulton et al., 1995;alone, through disruption of the ligand-binding chain of
the receptor, mice are capable of surviving in conven- Zhang et al., 1995).
tional rodent facilities, including our own. The exquisite
Experimental Proceduressusceptibility of Stat12/2 mice to MHV infection may re-
sult from the combined loss of both type I and type II
Cloning and Disruption of the Murine Stat1 GeneIFN responses, which has recently been shown to impair
A genomic library from strain 129 mice (Stratagene) was screened
some antiviral responses further (van den Broek et al., with a partial cDNAclone for mouse Stat1 (provided by C. Schindler).
1995). It will be of interest to determine the mechanisms A 16.5 kb genomic clone (412C) encoding 10 exons that spanned
of resistance in normal animals (e.g., antiviral responses 1201 nt of the Stat1 mRNA and encoded amino acids 188±588 (Fig-
ure 1A) was isolated and characterized using restriction mappingin hepatocytes, mobilization of immune cells) that are
and partial nucleotide sequencing (data not shown). Sequencedlost in Stat12/2 animals and the range of other viral dis-
exons were identical to the corresponding region of the publishedeases that rely on STAT1-mediated host defense.
cDNA (GenBank accession number U06924). A 2.5 kb XhoI±EcoRI
The present study indicates an apparent specificity fragment from a 59 portion and a 6.5 kb XbaI±SalI fragment from
of the STAT1 transcription factor for the IFN signaling the 39 end of the clone were subcloned into the region of the tar-
system. STAT1 becomes tyrosine phosphorylated by geting vector pPNT (Tybulewicz et al., 1991) flanking the neomycin
resistance cassette to produce the plasmid pPNT-91 (see Figuremany factors in addition to IFN, such as EGF, PDGF,
1A). Linearized pPNT-91 was electroporated into CCE ES cellsLIF, IL-6, IL-10, CSF-1, and angiotensin, at least in cell
(Bradley et al., 1984), and transfected cells were cultured in theculture. However, no defect in physiological responses
presence of G418 and gancyclovir by standard methods (Wurst
dependent upon these factors was detected in vivo. and Joyner, 1993). Cells resistant to both drugs were assayed for
Specifically, no defect was detected during embryogen- homologous recombination by the presence of a diagnostic RFLP.
esis or postnatal life in homozygous mutant animals that To generate homozygous mutant cell lines, we cultured Stat11/2
ES cells in the presence of 1.4 mg/ml G418 (Mortensen et al., 1992),would indicate compromised PDGF or EGF signaling.
and surviving colonies were assayed for loss of the wild-type Stat1In contrast, mice deficient for PDGF-B have been found
allele. Stat11/2 ES cells were injected into blastocysts of C57BL/6to exhibit renal, cardiovascular, and hematological ab-
mice (Bradley et al., 1984), and the resulting chimeric males were
normalities (Leveen et al., 1994); mice missing the EGF mated with C57BL/6 females. Heterozygous progeny were interbred
receptor exhibit a variety of phenotypes, from embry- to generate Stat12/2 animals. Stat11/2 animals were also mated to
onic lethality to abnormalities in skin, kidney, brain, liver, CD1 strain females, pathogen-free animals were obtained by em-
bryo transfer, and Stat12/2 progeny were derived by brother±sisterand gastrointestinal tract, depending on genetic back-
matings.ground (Sibilia and Wagner, 1995; Threadgill et al., 1995).
Likewise, normal production and differentiation of
Flow Cytometry
monocytes and macrophages were observed in Stat12/2 Single cell suspensions were prepared from fetal liver (15.5 dpc) or
animals, including growth of bone marrow macrophages newborn thymus (1 week postnatal) and stained with FITC- or PE-
in culture dependent on the presence of CSF-1. A very labeled monoclonal antibodies. Antibodies used were RA 3-6B2
(anti-B220), S7 (anti-CD43), 53-2.1 (anti-Thy1.2), RM2-5 (anti-CD2),different phenotype has been reported for animals with
RM4-5 (anti-CD4), 53-5.8 (anti-CD8), RB6-8C5 (anti-Gr-1), C71/16a mutation in the CSF-1 gene; these mice display numer-
(anti-CD18), and M1/70 (anti-CD11b) and were used as directed byous defects in the monocyte lineage, including os-
the supplier (PharMingen).teopetrosis and a substantial deficiency of macro-
phages (Hume and Favot, 1995; Wiktor-Jedrzejczak et Bone Marrow Macrophage Cultures
al., 1990; Yoshida et al., 1990). Bone marrow was harvested from femurs of adult animals (4±8
Lack of a requirement for STAT1 in vivo in response weeks) by rinsing marrow cavities with medium. Cells were subcul-
tured in RPMI supplemented with 20% FBS and 10% L cell±to these alternative activators may indicate that STAT1
conditioned medium. Adherent cells were cultured for 1 week, andactivation is irrelevant or redundant in all pathways other
confluent monolayers were harvested for RNA.than IFN. Functional redundancy could be provided by
STAT3, a closely related protein phosphorylated by
RNA Isolation and Analysis
many of the same cytokines that activate STAT1, includ- Total RNA was isolated from cells disrupted in guanidinium isothio-
ing LIF, IL-6, CSF-1, PDGF, and EGF, as well as IFN cyanate by centrifugation through CsCl, fractionated on formalde-
(Schindler and Darnell, 1995). STAT1 and STAT3 show hyde agarose gels, blotted onto nitrocellulose, and hybridized with
32P-labeled probes by standard methods.similar DNA binding specificities (Seidel et al., 1995;
Horvath et al., 1995); however, they also show distinct
Cell Culture and Protein Extractspatterns of binding to natural enhancer elements, possi-
Mouse embryo fibroblasts were prepared from individual 12±13 day
bly explaining an inability of STAT3 to substitute for embryos by standard methods (Todaro and Green, 1963) and were
STAT1 in mutant animals. In addition, specificity is con- genotyped by RFLP analysis. For induction of IFN genes, confluent
ferred on STAT1, but not on STAT3, by dimerization with monolayers treated with 50 mg/ml cycloheximide (Sigma) were inoc-
ulated for 1 hr with Newcastle disease virus at an moi of 10 in DMEphosphorylated STAT2and association with ISGF3g p48
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containing 0.1% BSA. Infected cells were cultured for 6 hr in the transcription initiation by RNA polymerase II in a soluble extract
from isolated mammalian nuclei. Nucl. Acids Res. 11, 1475±1489.continued presence of cycloheximide prior to lysis for RNA.
Cytoplasmic and nuclear extracts were prepared from cells as Fujita, T., Sakakibara, J., Sudo, Y., Miyamoto, M., Kimura, Y., and
previously described (Dignam et al., 1983). For immunoblotting, Taniguchi, T. (1988). Evidence for a nuclear factor(s), IRF-1, mediat-
STAT1 protein was immunoprecipitated using anti-91c (Schindler ing induction and silencing properties to human IFN-b gene regula-
et al., 1992) and immunoblotted using anti-STAT1 monoclonal anti- tory elements. EMBO J. 7, 3397±3405.
body from Transduction Labs. Gel shift DNA binding assays were
Fujita, T., Kimura, Y., Miyamoto, M., Barsoumian, E.L., and Tani-performed as described (Silvennoinen et al., 1993b).
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